🙏 Thank you for visiting Sinopep at TIDES!

It was a pleasure connecting with so many brilliant minds shaping the future of peptide and oligonucleotide therapeutics. If we had the chance to talk at the show, we hope it was the beginning of a great partnership.

If you were unable to meet with us at TIDES and would like to learn more about Sinopep’s capabilities and how we can support your clinical programs throughout the entire lifecycle, we invite you to explore the links below or reach out directly. We’d love to connect.

Sinopep is a full-service CDMO offering end-to-end support across peptides, oligonucleotides, and their conjugates. From early-phase development all the way through commercial manufacturing, whether you need dedicated FTE resources, process development and optimization, or large-scale GMP production, we’re built to support your program at every stage. And if large-scale oligo manufacturing is on your roadmap, our new GMP oligonucleotide facility is purpose-built for the growing demand for RNA-based medicines, with capacity to produce ASOs and siRNA at thousands of kilograms annually.

Want to keep exploring Sinopep?
🧬Oligonucleotide capabilities: https://www.sinopep.com/cdmo-services/oligonucleotide-nces/
🎥 Commercial manufacturing: https://www.youtube.com/@Sinopep
ᯅ Virtual facility tours: https://www.sinopep.com/facility-tours/